Document is current
Any future updates will be listed below
-
Authors
Valencia-Nieto, Laura https://orcid.org/0000-0003-3992-991X
Pinto-Fraga, José https://orcid.org/0000-0001-8179-9253
Blanco-Vázquez, Marta https://orcid.org/0000-0001-7054-3287
Fernández, Itziar https://orcid.org/0000-0002-5077-4448
López-Miguel, Alberto https://orcid.org/0000-0001-9429-1571
García-Vázquez, Carmen https://orcid.org/0000-0002-9281-6255
González-García, María J. https://orcid.org/0000-0003-3673-0585
Enríquez-de-Salamanca, Amalia https://orcid.org/0000-0003-1274-7796
Calonge, Margarita https://orcid.org/0000-0001-8178-4836
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04492878 at ClinicalTrials.govDocuments that mention this clinical trial
Short-Term Efficacy of Ophthalmic Cyclosporine: A 0.1% Cationic Emulsion in Dry Eye Patients Assessed Under Controlled Environment
https://doi.org/10.1007/s40123-024-00906-1
-
Funding
Funding for this research was provided by:
Santen (Investigator-initiated study grant)
- License Information
-
More Information
Article History
Received: 11 January 2024
Accepted: 5 February 2024
First Online: 6 March 2024
Declarations
:
: No conflicting relationship exists for any author. Disclosures of Dr. Margarita Calonge are the following: Research/clinical trials contracts, consultantships,advisory boards and/or lectures for Novartis, Santen Pharmaceutical, Johnson & Johnson, Horus Pharma, Fidia Farmaceutica, UrsaPharm GmbH, and Thea Laboratories. Alberto Lopez Miguel is an Editorial Board member of Ophthalmology and Therapy. Alberto Lopez Miguel was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The remaining authors have no relationship to disclose.
: The Ethics Committee of the Valladolid University Clinical Hospital (Valladolid, Spain) and the Spanish Drugs and Health Products Administration () (EudraCT number: 2019-000982-19) approved the trial. It was registered at the US National Institutes of Health (ClinicalTrials.gov, ID: NCT04492878). It was conducted at the Institute of Applied Ophthalmobiology, University of Valladolid, Valladolid, Spain. The study followed the tenets of the Declaration of Helsinki and the Good Clinical Practices.
